Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2018-01-31 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
募集资金管理制度（2018年1月）
Governance Information Classification · 95% confidence The document is titled '募集资金管理制度' which translates to 'Fundraising Capital Management System' and details the management, storage, usage, supervision, and regulatory compliance related to the company's raised funds. It references laws and regulations related to securities issuance and fundraising, discusses procedures for managing raised capital, usage restrictions, reporting, and oversight by auditors and independent directors. The document is a detailed internal policy or management system document rather than a financial report, earnings release, or announcement. It does not contain financial statements or results but rather governance and procedural rules for managing capital raised through securities issuance. This fits best under the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document is 7,346 characters long, indicating it is a substantive document, not a brief announcement or certification. Therefore, the classification is CGR with high confidence.
2018-01-31 Chinese
独立董事年报工作制度（2018年1月）
Governance Information Classification · 95% confidence The document is a formal internal governance policy titled 'Independent Directors Annual Report Work System' issued by the company. It outlines the responsibilities and procedures for independent directors in relation to the company's annual report preparation and audit process. It references company governance mechanisms, internal control, and compliance with regulatory requirements. The document is not an actual annual report, audit report, or financial statement, but rather a governance framework document related to the annual report process. It does not contain financial data or audit results. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2018-01-31 Chinese
关于召开2018年第一次临时股东大会的通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about the convening of the 2018 first extraordinary general meeting (临时股东大会) of the company, including meeting time, voting procedures, agenda items, and instructions for shareholders. It does not contain financial statements or results but rather information about the meeting logistics and proposals to be voted on. This matches the definition of a Proxy Solicitation & Information Statement (PSI), which provides materials sent to shareholders to inform and request votes for meetings. The document is not an announcement of voting results, nor is it a full annual or interim report, audit report, or earnings release. It is also not a regulatory filing or report publication announcement since it contains substantive meeting information and voting instructions. Therefore, the correct classification is PSI with high confidence.
2018-01-31 Chinese
董事、监事、高级管理人员所持本公司股份及其变动管理制度（2018年1月）
Governance Information Classification · 95% confidence The document is a detailed internal management system regarding the holdings and trading of company shares by directors, supervisors, and senior management personnel of 成都市贝瑞和康基因技术股份有限公司. It includes rules, procedures, and responsibilities related to shareholding disclosures, trading restrictions, reporting obligations, and penalties for violations. The content focuses on governance and compliance related to insider share transactions and management of shareholding information. It does not contain financial statements, audit opinions, earnings data, or investor presentations. It is not an announcement of a report but a governance document outlining internal rules and procedures. Therefore, the document fits best under the category of Governance Information (CGR).
2018-01-31 Chinese
中信建投证券股份有限公司关于公司2018年度预计日常关联交易的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from an independent financial advisor regarding the 2018 expected daily related party transactions of Chengdu Berry Genomics Co., Ltd. It includes extensive financial data, transaction details, pricing principles, and analysis of related party relationships and transaction amounts. The content is focused on the verification and explanation of related party transactions, which is typical of an Audit Report or Information document. It is not an annual report, earnings release, or a simple announcement. The length and detail confirm it is a substantive report, not just an announcement or certification. Therefore, the document fits best under the category of Audit Report / Information (AR). FY 2018
2018-01-31 Chinese
独立董事关于变更会计师事务所事前认可意见和独立意见
Audit Report / Information Classification · 95% confidence The document is a statement from independent directors regarding the pre-approval and independent opinions on the change of the company's accounting firm. It references regulatory guidelines and the company's articles of association, and it discusses the appointment of a new auditor for the 2018 financial report and internal control audit. The document does not contain actual financial statements or detailed audit results, but rather an opinion and approval related to the auditor change. This fits the category of Audit Report / Information (AR), which includes standalone audit reports and related opinions, excluding full annual reports. The document length is short and focused on audit firm change approval, not a full annual report or certification letter. Therefore, the classification is AR with high confidence. FY 2018
2018-01-31 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.